Advertisement

Significance of Serum Ferritin Concentrations in Lung Cancer and it’s Relation with Cellular Immunity

  • O. S. Sardas
  • O. Sancaktar
  • S. Sardas
  • H. Koc
Conference paper
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 13)

Abstract

Numerous reports have dealt with a search for substances which could be used either for early detection or to evaluate the course of therapy in lung cancer. The substances that were described to date could be categorised as either tumor associated antigens or biochemical tumor markers ; which were normal substances present in elevated levels in the serum of the tumor-bearing host. Similarly many different proteins, hormones and enzymes have been described as being potentially valuable tumor markers (Burt et al 1978). Recently, serum ferritin was being considered to be a reliable index in tumors and hematologic malignancies (Jones et al 1986). It was also shown that serum ferritin had an important role in the pathogenesis of abnormal immune function in Hodgkin disease and other malignancies (Hancock et al 1979, Matzner et al 1979). Especially in vitro studies exhibited a disturbance in T-lymphocyte function caused by ferritin (Peter et al 1984).

Keywords

Serum Ferritin Serum Ferritin Level Sheep Erythrocyte Hodgkin Disease Serum Ferritin Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Burt RW, Ratcliffe JG, Stack BHR, Cuthbeet J, Kennedy RS, Corker CS, Franchimont P, Spilg WGS and Stimson WH (1978) Serum biochemical markers in lung cancer. Br J Cancer 37: 714–717PubMedCrossRefGoogle Scholar
  2. Cox R, Gyde OH, Leyland J (1986) Serum ferritin levels in small cell lung cancer. Eur J Cancer Clin Oncol 22: 831–835PubMedCrossRefGoogle Scholar
  3. Hancock BW, Bruce L, May K and Richmond J (1979) Ferritin a sensitizing substance in the leucocyte migration inhibition test in patients with malignant lymphoma. Br J Hematol 43: 223–233CrossRefGoogle Scholar
  4. Jones PAE, Miller FM, Worwood M and Jacobs A (1973) Ferritinaemia in leukemia and Hodgkin’s disease. Br J Cancer 27: 212–217PubMedCrossRefGoogle Scholar
  5. Maria CL, Kristine W, James M (1982) Concenteration, structure and iron saturation of ferritins from normal human lung and lung tumors with graded histopathology. Enzyme 27: 189–198Google Scholar
  6. Matzner Y, Konijn AM and Hershko C (1980) Serum ferritin in hematologic malignancies. Am J Hematol 9: 13–22PubMedCrossRefGoogle Scholar
  7. Matzner Y, Hershko C, Polliack A, Konijn AM and Izak G (1979) Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol 42: 345–353PubMedCrossRefGoogle Scholar
  8. Peter EM, Robert WV and Philips MS (1981) Soluble tumor-associated markers in lung cancer extracts. Oncology 38: 147–153CrossRefGoogle Scholar
  9. Peter RP, Charles BS and Bernard B (1984) Ferritin bearing lymphocytes in patients with cancer. Cancer 53: 267–271CrossRefGoogle Scholar
  10. Rose NR, Friedman H, Fahey JL (1986) Manual of Clinical Immunology, 3 rd ed. American Society for Microbiology p 221Google Scholar
  11. Walters GO, Miller FM, Worwood M (1973) Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 26: 770–772PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • O. S. Sardas
    • 1
  • O. Sancaktar
    • 1
  • S. Sardas
    • 2
  • H. Koc
    • 1
  1. 1.Faculty of Medicine Department of Hematology and OncologyAnkara UniversityAnkaraTurkey
  2. 2.Faculty of Pharmacy, Department of ToxicologyGazi UniversityAnkaraTurkey

Personalised recommendations